Drug Database
Back to search

Denmark· DK-28107360725

Solipax

A tamsulosin und solifenacin product containing solifenacinsuccinat, tamsulosinhydrochlorid, registered in Denmark by Nordic Prime ApS. The same ATC class is registered in 9 of our 19 countries.

ATC G04CA53

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedSolipaxATCG04CA53REGISTER NO.DK-28107360725PACKS LISTED1CHECKEDSeptember 30, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about solifenacinsuccinat, tamsulosinhydrochloridAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tamsulosin und solifenacin is registered in 9 of 19 countries.

Countries holding a registration under ATC G04CA53 (tamsulosin und solifenacin), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 6 of them publish a price we can compare per daily dose
Search tamsulosin und solifenacin products by name

Tamsulosin und solifenacin · ATC G04CA53

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
Solifenacinsuccinat, TAMSULOSINHYDROCHLORID
Manufacturer
Nordic Prime ApS
Country
Denmark (DK)
ATC code
G04CA53
ATC class
Tamsulosin und Solifenacin
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28107360725

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under G04CA53

Tamsulosin und solifenacin, as other registers publish it.

All tamsulosin und solifenacin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e2098b26-389d-435b-83a1-784a12667d45
GET /v1/drugs/e2098b26-389d-435b-83a1-784a12667d45?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "tabletter med modificeret udløsning",
  "source": "dkma",
  "strength": "6+0,4 mg",
  "auth_role": "DKMA",
  "dk_drugid": "28107360725",
  "substance": "Solifenacinsuccinat, TAMSULOSINHYDROCHLORID",
  "auth_procedure": "Par-Imp",
  "in_medicinpriser": true,
  "registration_date_serial": "45820"
}
API referenceMCP serverPlans

See everything about tamsulosin und solifenacin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console